Esketamine Nasal Spray for Treatment-Resistant Bipolar II Depression: A Case Report
Psychiatry Investigation · 25.11.2025 · 22 (11) · 1334-1337
DOI: 10.30773/pi.2024.0312 ↗Kurz gefasst
Fallbericht in der Zeitschrift Psychiatry Investigation, erschienen am 25.11.2025. Verfasst von Hong-Ci Lin und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Education and Research, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 5 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Kaohsiung Veterans General Hospital.
Themen: Depression
Abstract (Originalsprache)
This case report discusses a 62-year-old male with treatment-resistant bipolar II depression and hypertension. After poor responses to multiple treatments, an add-on esketamine nasal spray (ESK-NS) was introduced in October 2022. Improvement was seen, and the patient’s depressive episode was nearly remitted during the maintenance phase. However, recurrence was noted when ESK-NS frequency was reduced to once every 2 months, indicating that the dosing frequency should be adjusted cautiously. The patient experienced common side effects, including dissociation, dizziness, and transient hypertension. Nifedipine was offered when his systolic blood pressure exceeded 160 mm Hg, accompanied by headache or dizziness. Blood pressure monitoring was essential throughout ESK-NS treatment. This report highlights esketamine’s potential for bipolar depression treatment and calls for further studies on its cardiovascular effects and proper management.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medical Education and Research, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan.
- School of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.
- Division of Neurology, Department of Internal Medicine, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan.
- Department of Psychiatry, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan.
Förderung
- Kaohsiung Veterans General Hospital
Zitieren
APA
Lin, H. C., Chang, C. Y., Lin, C. H., Chiang, Y. C., & Chang, C. H. (2025). Esketamine Nasal Spray for Treatment-Resistant Bipolar II Depression: A Case Report. Psychiatry Investigation, 22(11), 1334-1337. https://doi.org/10.30773/pi.2024.0312
Vancouver
Lin HC, Chang CY, Lin CH, Chiang YC, Chang CH. Esketamine Nasal Spray for Treatment-Resistant Bipolar II Depression: A Case Report. Psychiatry Investigation. 2025;22(11):1334-1337. doi:10.30773/pi.2024.0312
BibTeX
@article{Lin2025,
author = {Lin, Hong-Ci and Chang, Chia-Yu and Lin, Ching-Huang and Chiang, Yung-Chih and Chang, Cheng-Ho},
title = {Esketamine Nasal Spray for Treatment-Resistant Bipolar II Depression: A Case Report},
journal = {Psychiatry Investigation},
year = {2025},
volume = {22},
number = {11},
pages = {1334--1337},
doi = {10.30773/pi.2024.0312}
}
EUVIMED